Business Context and Reporting Period
Company: Apogee Acquisition Corp (Apogee)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2026
Business Model: Cayman Islands exempted company formed as a "blank check" SPAC to effect a business combination with one or more target businesses, focusing on advanced technologies (software, hardware, compute infrastructure, energy, etc.).
Status: As of June 30, 2026, the Company had not commenced operations. All activity relates to formation and the Initial Public Offering (IPO) consummated on April 8, 2026.
Key Financial Metrics
| Metric | Value |
|---|---|
| Total Assets | $175,356,675 |
| Cash Held in Trust | $174,798,579 |
| Operating Cash | $390,951 |
| Total Liabilities | $6,064,683 |
| Deferred Underwriting Commission | $6,000,000 |
| Net Income (3 Months Ended June 30, 2026) | $1,133,066 |
| Net Income (6 Months Ended June 30, 2026) | $1,078,066 |
| Operating Expenses (6 Months) | $358,013 |
| Investment Income (Trust) | $1,436,079 |
| Working Capital | $493,413 |
Material Changes vs. Prior Period
- Capitalization Event: The Company consummated its IPO on April 8, 2026, selling 17,250,000 Units (including full over-allotment) at $10.00 per unit, generating gross proceeds of $172,500,000. Simultaneously, it sold 470,000 Private Placement Units to the Sponsor for $4,700,000.
- Balance Sheet Transformation: Total assets increased from $139,709 (Dec 31, 2025) to $175,356,675 (June 30, 2026), driven primarily by the deposit of $173,362,500 into the Trust Account.
- Liabilities: Total liabilities increased from $153,585 to $6,064,683, primarily due to the recognition of a $6,000,000 deferred underwriting commission.
- Equity: Shareholders' deficit increased to $(5,506,587) due to the accretion of the carrying value of redeemable shares to their redemption value ($15,013,484 charge) offset by net income and proceeds from the private placement.
- Share Structure: As of June 30, 2026, there were 17,250,000 Class A ordinary shares subject to possible redemption and 5,750,000 Class B ordinary shares (Founder Shares) outstanding.
Outlook, Risks, and Management Commentary
- Going Concern: Management has determined that the timing of the mandatory liquidation date (July 8, 2027) raises substantial doubt about the Company's ability to continue as a going concern for the next twelve months. If a business combination is not consummated by this date, the Company will liquidate.
- Internal Controls: The Company identified material weaknesses in internal controls over financial reporting as of June 30, 2026. Specifically, there were deficiencies in the review of liabilities and related party transactions (specifically regarding legal and consulting services provided by the CEO's firm).
- Advisory Agreement: On May 28, 2026, the Company entered into a capital markets advisory agreement with ARC Group Securities LLC, paying a $120,000 fee. ARC Group is entitled to a 4% transaction fee on any future private placement.
- Redemption Rights: Public shareholders may redeem their shares for a pro rata portion of the Trust Account ($10.05 per share plus interest) in connection with a business combination or liquidation.
- Risks: Risks include the inability to complete a business combination, market volatility due to geopolitical conflicts (Russia-Ukraine, Middle East), and the potential for the Trust Account value to be reduced by third-party claims if the Sponsor cannot satisfy indemnification obligations.
Investor Verification Checklist
- Trust Account Balance: Verify the current balance of the Trust Account ($174,798,579) and the per-share redemption value ($10.13 as of June 30, 2026).
- Internal Control Remediation: Review subsequent filings to confirm if the material weaknesses regarding related party transactions and liability reviews have been remediated.
- Related Party Transactions: Scrutinize the ongoing fees paid to the Sponsor ($10,000/month) and the legal services provided by LawVisory PLLC (founded by the CEO), noting the unpaid balance of $14,851.
- Liquidation Deadline: Confirm the July 8, 2027 deadline for consummating a business combination and any potential extensions.
- Deferred Fees: Note the $6,000,000 deferred underwriting commission payable only upon the successful completion of a business combination.